Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.
Body mass index
Meta-analysis
Prostate cancer
Prostate-specific antigen
Screening
Systematic review
Journal
Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
23
08
2019
accepted:
27
02
2020
pubmed:
13
3
2020
medline:
19
8
2020
entrez:
13
3
2020
Statut:
ppublish
Résumé
The relationship between body mass index (BMI) and prostate cancer remains unclear. However, there is an inverse association between BMI and prostate-specific antigen (PSA), used for prostate cancer screening. We conducted this review to estimate the associations between BMI and (1) prostate cancer, (2) advanced prostate cancer, and (3) PSA. We searched PubMed and Embase for studies until 02 October 2017 and obtained individual participant data from four studies. In total, 78 studies were identified for the association between BMI and prostate cancer, 21 for BMI and advanced prostate cancer, and 35 for BMI and PSA. We performed random-effects meta-analysis of linear associations of log-PSA and prostate cancer with BMI and, to examine potential non-linearity, of associations between categories of BMI and each outcome. In the meta-analyses with continuous BMI, a 5 kg/m There is little or no evidence of an association between BMI and risk of prostate cancer or advanced prostate cancer, and strong evidence of an inverse and non-linear association between BMI and PSA. The association between BMI and prostate cancer is likely biased if missed diagnoses are not considered.
Identifiants
pubmed: 32162172
doi: 10.1007/s10552-020-01291-3
pii: 10.1007/s10552-020-01291-3
pmc: PMC7105428
doi:
Substances chimiques
KLK3 protein, human
EC 3.4.21.-
Kallikreins
EC 3.4.21.-
Prostate-Specific Antigen
EC 3.4.21.77
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
431-449Subventions
Organisme : Wellcome Trust
ID : 102432/Z/13/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M014533/1
Pays : United Kingdom
Références
BMJ. 1988 Sep 17;297(6650):713-5
pubmed: 3147735
Am J Epidemiol. 2009 Apr 15;169(8):937-45
pubmed: 19240222
Zhonghua Liu Xing Bing Xue Za Zhi. 1996 Dec;17(6):343-5
pubmed: 9387599
BMC Cancer. 2016 Aug 17;16:643
pubmed: 27535659
Asian Pac J Cancer Prev. 2011;12(8):1937-40
pubmed: 22292628
J Urol. 2012 May;187(5):1589-93
pubmed: 22425083
Int J Epidemiol. 2019 Aug 1;48(4):1294-1304
pubmed: 30879056
Cancer Causes Control. 1997 Mar;8(2):229-38
pubmed: 9134247
J Natl Cancer Inst. 1995 May 3;87(9):652-61
pubmed: 7752270
Urol Int. 2012;89(1):52-6
pubmed: 22627168
Urology. 2007 Jan;69(1):103-7
pubmed: 17270628
Int J Obes (Lond). 2014 Jun;38(6):857-64
pubmed: 24247373
BJU Int. 2009 Jun;103(11):1487-91
pubmed: 19076145
J Urol. 2009 Dec;182(6):2646-51
pubmed: 19836806
Cancer. 1989 Aug 1;64(3):598-604
pubmed: 2743254
JAMA. 2007 Nov 21;298(19):2275-80
pubmed: 18029831
Int J Clin Exp Med. 2015 Mar 15;8(3):4557-62
pubmed: 26064384
Lancet. 2014 Aug 30;384(9945):755-65
pubmed: 25129328
J Urol. 2006 Feb;175(2):500-4; discussion 504
pubmed: 16406980
Oncol Lett. 2015 Mar;9(3):1307-1312
pubmed: 25663903
Cancer Causes Control. 1999 Oct;10(5):355-67
pubmed: 10530605
Cancer Causes Control. 2006 Oct;17(8):989-1003
pubmed: 16933050
Oncol Rep. 2004 Apr;11(4):887-92
pubmed: 15010890
Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):501-8
pubmed: 21242331
J Natl Cancer Inst. 1997 Mar 5;89(5):385-9
pubmed: 9060961
Cancer Causes Control. 2015 Oct;26(10):1507-15
pubmed: 26243447
Lancet Oncol. 2014 Sep;15(10):1109-18
pubmed: 25163905
Cancer Causes Control. 2005 Aug;16(6):637-41
pubmed: 16049801
J Urol. 2008 Mar;179(3):886-90; discussion 890-1
pubmed: 18207169
J Natl Cancer Inst. 2012 Jan 18;104(2):125-32
pubmed: 22228146
Prostate. 2011 Nov;71(15):1631-7
pubmed: 21432865
Eur J Epidemiol. 2005;20(2):155-60
pubmed: 15792282
Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):851-8
pubmed: 22402288
Epidemiology. 2001 Sep;12(5):546-51
pubmed: 11505174
PLoS One. 2014 Sep 03;9(9):e106677
pubmed: 25184215
Rev Urol. 2008 Fall;10(4):262-80
pubmed: 19145270
BMC Med. 2017 Jul 13;15(1):115
pubmed: 28701188
Int J Cancer. 2017 Feb 15;140(4):818-824
pubmed: 27861848
Am J Epidemiol. 2000 Mar 15;151(6):541-9
pubmed: 10733035
Cancer Epidemiol. 2016 Dec;45:40-46
pubmed: 27693812
Prostate Cancer. 2012;2012:524206
pubmed: 23304521
Am J Epidemiol. 2005 Jun 15;161(12):1107-14
pubmed: 15937019
J Clin Oncol. 2005 Jul 20;23(21):4742-54
pubmed: 16034050
Am J Epidemiol. 2013 Jun 15;177(12):1388-98
pubmed: 23722011
Urol Oncol. 2015 Nov;33(11):494.e1-7
pubmed: 26278366
Cancer Causes Control. 2012 May;23(5):769-77
pubmed: 22467266
Br J Cancer. 2003 Oct 6;89(7):1237-42
pubmed: 14520453
Prostate. 2000 May 1;43(2):136-43
pubmed: 10754529
Cancer. 2008 Nov 1;113(9):2464-70
pubmed: 18666213
BJU Int. 2000 Apr;85(6):665-71
pubmed: 10759662
Onkologie. 2007 Nov;30(11):538-42
pubmed: 17992023
Cancer Causes Control. 2016 Dec;27(12):1465-1474
pubmed: 27830401
Cancer. 2007 Feb 15;109(4):675-84
pubmed: 17211863
Lancet. 2008 Feb 16;371(9612):569-78
pubmed: 18280327
Turk J Urol. 2017 Sep;43(3):284-288
pubmed: 28861299
Urology. 2008 Sep;72(3):561-5
pubmed: 18514773
Res Synth Methods. 2017 Sep;8(3):281-289
pubmed: 28453179
J Urol. 2005 Dec;174(6):2169-73
pubmed: 16280757
Epidemiology. 1994 May;5(3):276-82
pubmed: 8038241
Asian J Urol. 2015 Jul;2(3):158-162
pubmed: 29264136
J Natl Cancer Inst. 2009 Sep 16;101(18):1272-9
pubmed: 19700655
Cancer Causes Control. 1999 Aug;10(4):269-75
pubmed: 10482485
Prostate. 2005 Mar 1;62(4):316-21
pubmed: 15389806
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2561-7
pubmed: 25150281
Int J Cancer. 2003 Sep 10;106(4):594-599
pubmed: 12845658
Asian J Androl. 2013 Nov;15(6):770-2
pubmed: 23912312
Cancer Causes Control. 2013 Dec;24(12):2143-55
pubmed: 24048969
Int J Epidemiol. 2010 Apr;39(2):417-20
pubmed: 19926667
Cancer Causes Control. 2010 Dec;21(12):2069-77
pubmed: 20680433
BMJ. 2017 Feb 28;356:j477
pubmed: 28246088
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Int J Cancer. 1999 Mar 1;80(5):699-703
pubmed: 10048970
Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):557-63
pubmed: 9264267
Asian J Androl. 2011 Jul;13(4):640-3
pubmed: 21170076
Ann Oncol. 2012 Jul;23(7):1665-71
pubmed: 22228452
Int J Cancer. 2016 Jul 1;139(1):50-7
pubmed: 26914149
Korean J Urol. 2011 Jun;52(6):401-5
pubmed: 21750751
Int J Cancer. 2005 Jan 1;113(1):148-57
pubmed: 15386435
N Engl J Med. 2013 Aug 15;369(7):603-10
pubmed: 23944298
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):148-54
pubmed: 19124492
J Clin Pharmacol. 2013 Jul;53(7):773-8
pubmed: 23686462
Urology. 2014 Jan;83(1):81-7
pubmed: 24044911
Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1335-41
pubmed: 11142419
Int J Cancer. 2003 Jan 10;103(2):241-5
pubmed: 12455039
J Urol. 2007 Feb;177(2):493-8
pubmed: 17222617
Chin J Cancer Res. 2016 Feb;28(1):58-64
pubmed: 27041927
Ann Epidemiol. 2000 Aug;10(6):361-9
pubmed: 10964002
Cancer Causes Control. 2017 Jun;28(6):497-528
pubmed: 28361446
Asian Pac J Cancer Prev. 2016;17(4):1937-45
pubmed: 27221879
Asian Pac J Cancer Prev. 2012;13(7):3179-85
pubmed: 22994730
Int J Cancer. 2009 Jun 1;124(11):2683-9
pubmed: 19189403
Int J Cancer. 2015 Oct 1;137(7):1699-708
pubmed: 25810218
Anticancer Res. 2004 May-Jun;24(3b):2069-72
pubmed: 15274402
Cancer Causes Control. 2018 Mar;29(3):383-388
pubmed: 29453511
Eur Urol. 2013 May;63(5):800-9
pubmed: 23219374
Actas Urol Esp. 2012 May;36(5):302-5
pubmed: 22398256
Urology. 2008 May;71(5):787-91
pubmed: 18267334
Int J Cancer. 2015 Apr 15;136(8):1940-7
pubmed: 25264293
BMC Cancer. 2012 Jan 19;12:25
pubmed: 22260413
Asian Pac J Cancer Prev. 2011;12(3):743-7
pubmed: 21627376
Int J Cancer. 1998 Mar 30;76(1):25-8
pubmed: 9533757
Int J Cancer. 2007 Aug 15;121(4):810-8
pubmed: 17455257
Cancer Causes Control. 2001 Feb;12(2):187-93
pubmed: 11246848
Cancer. 2005 Mar 1;103(5):1092-5
pubmed: 15668913
Am J Epidemiol. 2004 Feb 1;159(3):259-68
pubmed: 14742286
J Natl Cancer Inst. 2001 May 16;93(10):783-9
pubmed: 11353789
Am J Epidemiol. 2007 Jun 1;165(11):1271-9
pubmed: 17395597
Urology. 2007 Dec;70(6):1121-6
pubmed: 18158031
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1331-5
pubmed: 16835332
Eur J Cancer. 2016 Dec;69:61-69
pubmed: 27816833
Nat Clin Pract Urol. 2007 Nov;4(11):605-14
pubmed: 17982437
Cancer. 1999 Jul 15;86(2):312-5
pubmed: 10421267
Int J Cancer. 2012 Oct 1;131(7):1711-9
pubmed: 22213024
Br J Cancer. 2006 Mar 13;94(5):740-2
pubmed: 16465189
J Urol. 2012 Apr;187(4):1228-33
pubmed: 22335864
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2413-21
pubmed: 19723920
Cancer. 2012 Dec 15;118(24):6199-206
pubmed: 23090855
Br J Cancer. 2011 Sep 27;105(7):1061-8
pubmed: 21847119
Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):63-9
pubmed: 17179486
Am J Clin Oncol. 2012 Oct;35(5):490-2
pubmed: 21577087
Int J Cancer. 2006 Jan 15;118(2):458-66
pubmed: 16049963
Int J Cancer. 2006 Oct 1;119(7):1690-4
pubmed: 16646073
Int J Cancer. 2004 Jun 10;110(2):278-83
pubmed: 15069694
Br J Cancer. 2004 Jun 1;90(11):2176-80
pubmed: 15150581
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1350-6
pubmed: 19383895
Clin Chim Acta. 2015 Aug 25;448:220-7
pubmed: 26093340
J Urol. 2009 Jul;182(1):106-10; discussion 110-1
pubmed: 19450837
Int J Cancer. 2015 Oct 1;137(7):1749-57
pubmed: 25821151
Br J Cancer. 2009 Jun 2;100(11):1799-805
pubmed: 19436298
J Cancer. 2016 Oct 22;7(14):2061-2066
pubmed: 27877221
Urology. 2013 May;81(5):949-55
pubmed: 23477756
Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):509-13
pubmed: 8827354
Int J Cancer. 1997 Nov 27;73(5):634-8
pubmed: 9398038
Nutr Cancer. 2013;65(7):961-8
pubmed: 24053657
Int J Cancer. 2010 Oct 1;127(7):1660-8
pubmed: 20087861
BMC Cancer. 2012 Jan 18;12:23
pubmed: 22257467
Am J Epidemiol. 2006 Oct 15;164(8):769-74
pubmed: 16952929
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120